The transition of epithelial cells to fibromioblasts. Mechanisms involved and its possible relationship with renal fibrosis;La transición de células epiteliales a miofibroblastos. Mecanismos involucrados y su posible relación con la fibrosis renal

Nefrologia

Volumn 27, Issue 6, 2007, Pages 681-688

  Docherty, N G ^a   Morales, A I ^b   Lopez Novoa J M ^b   Pérez Barriocanal, Fernando ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL ADHESION; CELL MOTION; CELL POLARITY; EPITHELIUM CELL; FIBROSIS; HUMAN; KIDNEY; MYOBLAST; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL POLARITY; EPITHELIAL CELLS; FIBROSIS; HUMANS; KIDNEY; MYOBLASTS;

EID: 42949131795     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Strutz F, Müller GA: Renal fibrosis and the origin of the renal fibroblast. Nephrol Dial Transplant 21: 3368-3370, 2006.
2. Port FK, Fenton SSA, Mazzuchi N: ESRD throughout the world: morbidity, mortality and quality of life. Kidney Int 57: S1-S2, 2000.
3. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
4. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Müller GA, Strutz F, Kalluri R: Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 159: 1313-1321, 2001.
5. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
6. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
7. Yamashita S, Maesshima A, Nojima Y: Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 16: 2044-2051, 2005.
8. Li Y, Yang J, Dai C, Wu C, Liu Y: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112: 503-516, 2003.
9. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Müller GA, Colasanti G, D'Amico G: Epithelial-mesenchymal transition of tubular epitelial cells in human renal biopsies. Kidney Int 62: 137-146, 2002.
10. Thiery JP: Epithelial-mesenchymal transition in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
11. 1 by human dermal fibroblasts. J Invest Dermatol 97: 634-637, 1991.
12. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M: Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65: 871-880, 2004.
13. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112(10): 1486-1494, 2003.
14. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999.
15. Okada H, Danoff TM, Kalluri R, Neilson EG: The early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol 273: 563-574, 1997.
16. Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP, Larue L: IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20: 4942-4950, 2001.
17. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61: 1714-1728, 2002.
18. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL: Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 276: 46707-46713, 2001.
19. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
20. Yu L, Hebert MC, Zhang YE: TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21: 3749-3759, 2002.
21. Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, Runyan RB: TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 208: 530-545, 1999.
22. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003.
23. Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293, 2001.
24. Gibson MC, Perrimon N: Apicobasal polarization: epithelial form and function. Curr Opin Cell Biol 15: 747-752, 2003.
25. Bilder D: Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev. 18: 1909-1925, 2004.
26. Reichert M, Muller T, Hunziker W: The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of β-catenin/Tcf/Lef signalling. J Biol Chem 275: 9492-9500, 2000.
27. Pérez-Moreno M, Jamora C, Fuchs E: Sticky business: orchestrating cellular signals at adherens junction. Cell 112: 535-548, 2003.
28. Knust E: Regulation of epithelial cell shape and polarity by cell-cell adhesion. Mol Membr Biol 19: 113-120, 2002.
29. Lee DBN, Huang E, Ward HJ: Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290: F20-F34, 2006.
30. Lan M, Kojima T, Osanai M, Chiba H, Sawada N: Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis 25: 2385-2395, 2004.
31. Batlle E, Sancho E, Franci C, Domínguez D, Monfar M, Baulida J, García de Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
32. Ohkubo T, Ozawa M: The transcription factor Snail dowregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117: 1675-1685, 2004.
33. Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-166, 2002.
34. Peinado H, Quintanilla M, Cano A: Transforming growth factor beta 1 induces snail transcription factor in epithelial cell lines. Mechanisms for epithelial-mesenchymal transitions. J Biol Chem 278: 21113-21123, 2003.
35. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K: Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90: 1265-1273, 2004.
36. Kim K, Lu Z, Hay ED: Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26: 463-476, 2002.
37. Masszi A, Fan L, Rosivall L, McCulloch CA, Rotstein OD, Mucsi I, Kapus A: Integrity of cell-cell contacts is a critical regulator of TGF-β1-induced epithelial-to-myofibroblast transition. Role for β-catenin. Am J Pathol 165: 1955-1967, 2004.
38. Behrens J, Von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642, 1996.
39. Tian YC, Fraser D, Attisano L, Phillips AO: TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol 285: F130-F142, 2003.
40. Labbe E, Letamendia A, Attisano L: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97: 8358-8363, 2000.
41. Tian YC, Phillips AO: Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol 160: 1619-1628, 2002.
42. Barrios-Rodiles M, Brown KR, Ozdamar B, Bosé R, Liu Z, Donovan RS, Shinjo F, Liu Y, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, Wrana JL: High-throughput mapping of a dynamic signalling network in mammalian cells. Science 307: 1621-1625, 2005.
43. Ozdamar B, Bosé R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL: Regulation of the polarity protein Par6 by TGF-β receptors controls epithelial cell plasticity. Science 307: 1603-1609, 2005.
44. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R: Renal fibrosis. Extracellular matriz microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 160: 2001-2008, 2002.
45. Lenz O, Elliot SJ, Stetler-Stevenson WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11: 574-581, 2000.
46. Li M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231: 20-27, 2006.
47. Ichikawa Y, Ishikawa T, Momiyama N, Kamiyama M, Sakurada H, Matsuyama R, Hasegawa S, Chishima T, Hamaguchi Y, Fujii S, Saito S, Kubota K, Hasegawa S, Ike H, Oki S, Shimada H: Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol Rep 15: 311-315, 2006.
48. Krizbai IA, Bauer H, Amberger A, Henning B, Szabo H, Fuchs R, Baue HC: Growth factor-induced morphological and molecular characteristics in cerebral endothelial cells. Eur J Cell Biol 79: 594-600, 2000.
49. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, El Nahas AM: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12: 43-50, 1997.
50. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 50: 123-127, 1997.
51. Kropp BP, Zhang Y, Tomasek JJ, Cowan R, Furness PD, Vaughan MB, Parizi M, Cheng EY: Characterization of cultured bladder smooth muscle cells: assessment of in vitro contractility. J Urol 162: 1779-1784, 1999.
52. Powell DW, Miffin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277: C1-C19, 1999.
53. Bar-Sagi D, Hall A: Ras and Rho GTPases: a family reunion. Cell 103: 227-238, 2000.
54. Bernards A: GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and drosophila. Biochim Biophys Acta 1603: 47-82, 2003.
55. Sander EE, Ten Klooster JP, Van Delft S, Van der Kammen RA, Collard JG: Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147: 1009-1022, 1999.
56. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 420: 629-635, 2002.
57. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000.
58. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636, 1981.
59. Mochan E, Keler T: Plasmin degradation of cartilage proteoglycan. Biochim Biophys Acta 800: 312-315, 1984.
60. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP: Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinasas. Cancer Res 50: 5997-6001, 1990.
61. He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86: 2632-2636, 1989.
62. Nagase H, Enghild JJ, Suzuki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 29: 5783-5789, 1990.
63. Norman JT, Orphanides C, García P, Fine LG: Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol 7: 463-469, 1999.
64. Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, Gilbert RE, Pollock CA: Integrated actions of transforming growth factor-{beta}1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol 288: F800-F809, 2005.
65. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
66. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF: Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 5(6): 1367-1374, 2005.
67. Diamond JR, Ricardo SD, Klahr S: Mechanisms of intersticial fibrosis in obstructive nephropathy. Semin Nephrol 18: 594-602, 1998.
68. Rodríguez-Peña A, Eleno N, Düwell A, Arévalo M, Pérez-Barriocanal F, Flores O, Docherty N, Bernabéu C, Letarte M, López-Novoa JM: Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40: 712-720, 2002.
69. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M: Cyclosporine- associated chronic nephropathy. N Engl J Med 311: 699-705, 1984.
70. Slattery C, Campbell E, McMorrow T, Ryan MP: Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 167: 395-407, 2005.
71. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of fibroblast-specific protein 1 (FSP1). J Cell Biol 130: 393-405, 1995.
72. Okada H, Strutz F, Danoff TM, Kalluri R, Neilson EG: Possible mechanisms of renal fibrosis. Contrib Nephrol 118: 147-154, 1996.
73. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG: Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 58: 587-597, 2000.
74. Sutaria PM, Ohebshalom M, McCaffrey TA, Vaughan Jr ED, Felsen D: Transforming growth factor-β receptor type I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 62: 1965-1972, 1998.
75. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K, Liu Y: Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538, 2002.
76. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R: Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285: F1060-F1067, 2003 A.
77. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S: Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13(1): S14-S21, 2002.
78. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA: Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63: 2037-2049, 2003.